Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (411-420 of 487) with videos related to

Pageof 49
Sort By:
Therapeutic Advances in Hematology|May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinibNichola Cooper, Ivy Altomare, Mark R Thomas, et al.
British Journal of Haematology|April 25, 2025
Fetal-neonatal alloimmune thrombocytopenia: Mothers are affected tooEleanore A McFarland, Emilie L Vander Haar, Margaret H McKelvy, et al.
Blood|November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicityKeri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Blood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|November 13, 2018
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND studyAbderrahim Khelif, Mansoor N Saleh, Abdulgabar Salama, et al.
British Journal of Haematology|November 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extensionNichola Cooper, James B Bussel, Maciej Kaźmierczak, et al.
Pediatric Research|June 27, 2002
Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopeniaL Porcelijn, C C Folman, M de Haas, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Blood|April 20, 2011
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopeniaJames B Bussel, George R Buchanan, Diane J Nugent, et al.
Pageof 49

Showing results (411-420 of 487) with videos related to

Sort By:
Pageof 49
Therapeutic Advances in Hematology|May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinibNichola Cooper, Ivy Altomare, Mark R Thomas, et al.
British Journal of Haematology|April 25, 2025
Fetal-neonatal alloimmune thrombocytopenia: Mothers are affected tooEleanore A McFarland, Emilie L Vander Haar, Margaret H McKelvy, et al.
Blood|November 30, 2011
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicityKeri B Sanborn, Emily M Mace, Gregory D Rak, et al.
Blood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|November 13, 2018
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND studyAbderrahim Khelif, Mansoor N Saleh, Abdulgabar Salama, et al.
British Journal of Haematology|November 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extensionNichola Cooper, James B Bussel, Maciej Kaźmierczak, et al.
Pediatric Research|June 27, 2002
Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopeniaL Porcelijn, C C Folman, M de Haas, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Blood|April 20, 2011
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopeniaJames B Bussel, George R Buchanan, Diane J Nugent, et al.
Pageof 49